207 related articles for article (PubMed ID: 21367964)
1. Quality of life in thyroid eye disease: impact of quality of care.
Estcourt S; Quinn AG; Vaidya B
Eur J Endocrinol; 2011 May; 164(5):649-55. PubMed ID: 21367964
[TBL] [Abstract][Full Text] [Related]
2. Thyroid eye disease.
Cockerham KP; Chan SS
Neurol Clin; 2010 Aug; 28(3):729-55. PubMed ID: 20637998
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and responsiveness of the patient-reported TED-QOL to rehabilitative surgery in thyroid eye disease.
Fayers T; Fayers PM; Dolman PJ
Orbit; 2016 Dec; 35(6):328-334. PubMed ID: 27599688
[TBL] [Abstract][Full Text] [Related]
4. The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of Life.
Wickwar S; McBain H; Ezra DG; Hirani SP; Rose GE; Newman SP
Ophthalmology; 2015 Dec; 122(12):2568-76.e1. PubMed ID: 26421706
[TBL] [Abstract][Full Text] [Related]
5. The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis.
Estcourt S; Vaidya B; Quinn A; Shepherd M
Clin Endocrinol (Oxf); 2008 Apr; 68(4):635-9. PubMed ID: 17973942
[TBL] [Abstract][Full Text] [Related]
6. Measuring Health-Related Quality of Life in Thyroid Eye Disease.
Sharma A; Stan MN; Rootman DB
J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S27-S35. PubMed ID: 36346683
[TBL] [Abstract][Full Text] [Related]
7. Thyroid eye disease: a review.
Weiler DL
Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
[TBL] [Abstract][Full Text] [Related]
8. Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.
Dietrich A; Taylor P; White P; Wilson V; Uddin J; Lee RWJ; Dayan C; Jackson S;
Psychol Health Med; 2018; 23(sup1):1341-1355. PubMed ID: 30092670
[TBL] [Abstract][Full Text] [Related]
9. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease.
Fayers T; Dolman PJ
Br J Ophthalmol; 2011 Dec; 95(12):1670-4. PubMed ID: 21951566
[TBL] [Abstract][Full Text] [Related]
10. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
Son BJ; Lee SY; Yoon JS
Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
[TBL] [Abstract][Full Text] [Related]
12. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
13. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.
Quinn AS; Dujardin LR; Knight B; Benzimra J; Quinn AG; Vaidya B
Int Ophthalmol; 2018 Feb; 38(1):301-306. PubMed ID: 28181061
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in Graves' ophthalmopathy.
Wiersinga WM
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):359-70. PubMed ID: 22632371
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
16. How patients experience thyroid eye disease.
Smith TJ; Hegedüs L; Lesser I; Perros P; Dorris K; Kinrade M; Troy-Ott P; Wuerth L; Nori M
Front Endocrinol (Lausanne); 2023; 14():1283374. PubMed ID: 38027128
[TBL] [Abstract][Full Text] [Related]
17. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
18. Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy.
Du Y; Ye H; Li K; Xiao X; Chen R; He JF; Yang H
Curr Eye Res; 2014 May; 39(5):532-6. PubMed ID: 24215175
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
[TBL] [Abstract][Full Text] [Related]
20. Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States.
Wang Y; Sharma A; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Massry G; Douglas RS
Ophthalmol Ther; 2021 Mar; 10(1):75-87. PubMed ID: 33196932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
